Vedang Murthy: He Multicentre phase 3 RCT of Adj RT post RCIC+ Chemo accrued the last patient
Vedang Murthy, Professor GU-Radiation Oncology at Tata Memorial Centre Mumbai, shared a post on X:
“Patience and Perseverance from the entire GU team at Tata Memorial Hospital. The Multicentre phase 3 RCT of Adj RT post RCIC+ Chemo accrued the last patient (n=153) Took 8 years but we got there in the end. Phew! Interested in the early results? Coming soon at a conference near you!
Great moral and intellectual support from Paul Sargos at GETUG, John Christodouleas and Brian C. Baumann with their initial work. Will learn much from the data on toxicity and outcomes of Adj RT (inspite of NACT/Adj CT). Hope it impacts in the guidelines.
Interested in reading the protocol?
Interested in the early results?
Coming soon at a conference near you!”
Source: Vedang Murthy/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023